An amendment to the TRIPS Agreement entered into force on 23 January 2017

摘要

The amendment eases poorer WTO members' access to medicines by allowing generic versions of patented medicines to be produced under compulsory licences (i.e. without the consent of the patent owner) for export to countries that cannot manufacture the needed medicines themselves.